RAD BIOMED ACCELERATOR ADDS DR. SIGAL KREMER-TAL, MD TO ITS TOP MANAGEMENT TEAM
-- Dr. Kremer Tal joins RAD BioMed from Novartis US --
Tel – Aviv, Israel, December 1st, 2010 – RAD BioMed, a leading success-accelerator for Israeli life science startups, today announced that Dr. Sigal Kremer-Tal, MD has joined its top management team as the new VP Scouting & Operations.
Before joining Rad Biomed Dr. Kremer-Tal has worked in clinical research at Novartis US. Prior to that, she has worked at Mount Sinai School of Medicine, doing basic science research in cancer genetics. Dr. Kremer Tall has an MD from the Hebrew University, at Hadassah medical school and is trained in Internal Medicine from Rabin medical center, Beilinson campus.
Dr. Kremer-Tal Dr. Kremer-Tal steps in for Dr. Eyal Orion, the previous VP Scouting & operations, who co-founded Vascular Graft Solutions, one of RAD Biomed’s portfolio companies, and has now been appointed as its full-time CEO.
About RAD BioMed
RAD BioMed is a success-accelerator for Israeli life science startups. With state-of-the-art facilities, a team of entrepreneurial experts and broad contact networks, RAD BioMed incubates startups at various stages in the medical devices, biopharma and diagnostic sectors. The Tel-Aviv-based accelerator empowers innovation by ‘de-risking’ the start-up process and providing comprehensive support, including funding, mentoring and umbrella business development, marketing and administration services. RAD BioMed is the sole incubator in Israel to provide its portfolio companies with access to state-of-the-art biotechnology laboratories. RAD BioMed is owned by Yehuda Zisapel, President and Founder of the RAD Group, a world leader in voice and data communications technologies, and Professor Nava Zisapel, founder of Neurim Ltd., one of Israel’s leading BioPharma companies. RAD BioMed’s professional staff includes seasoned entrepreneurs and veteran professionals with broad experience in finance, medicine and biotechnology.